Benchmark for the future.

OSMOTRON© WFI.

4.6.2018 9:00  

 

Water for injections. Sustainable. Economical. Safe.

 

The OSMOTRON© has for two decades been the benchmark for compact, standardised systems for producing purified water. The OSMOTRON© WFI will be promoted at ACHEMA as the benchmark for membrane-based, cold generation of water for injection purposes.

 

The frame-mounted compact unit turns drinking water into the best quality WFI, with capacities of up to 15 m³/h WFI possible on a single frame. Its triple membrane barrier ensures maximum quality and optimum safety. After the two-stage reverse osmosis, the SEPTRON WFI electrodeionisation module, with its integrated ultrafiltration, is the final treatment step and safety barrier.

 

The OSMOTON© WFI impresses with its high water yield and resource-saving process design, resulting in a cost reduction per m³ of WFI of up to 70% below the cost of conventional thermal systems. At the same time less investment and space are needed, while the system's robustness makes it suitable for a wide spectrum of feed water quality.

 

The performance of the OSMOTRON© WFI was tested as part of an extensive long-term testing programme with an independent university.

 

For more information, please visit www.bwt-pharma.com

Correspondence for press queries:
BWT Pharma & Biotech GmbH
Carl-Benz Str. 4
74321 Bietigheim-Bissingen (Germany)
Tel: +49 (0) 7142 / 3737 500
E-Mail: office@bwt-pharma.com
www.bwt-pharma.com

















BWT´s innovatieve streven naar water van perfecte kwaliteit